TBE Vaccination Breakthrough Cases—Does Age Matter?
Tick-borne encephalitis (TBE) vaccines are highly effective in preventing TBE and vaccine failures (VF) are rare events. In this study, we compared the age distribution of TBE cases and TBE VF in three endemic countries: Sweden, Southern Germany, and Latvia. While the age distribution of TBE cases w...
Main Authors: | Heinz-J. Schmitt, Gerhard Dobler, Dace Zavadska, Zane Freimane, Dimitrios Fousteris, Wilhelm Erber, Luis Jodar, Andreas Palmborg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/8/932 |
Similar Items
-
Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination
by: Julia Feige, et al.
Published: (2020-02-01) -
Epidemiology of Tick-Borne Encephalitis (TBE) in Germany, 2001–2018
by: Wiebke Hellenbrand, et al.
Published: (2019-03-01) -
Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017
by: Benno Kohlmaier, et al.
Published: (2021-06-01) -
AGES AND SEX DEPENDENCE OF SPECIFIC IMMUNE RESPONSE IN THE PERSONS INOCULATED WITH TICKSBORNE ENCEPHALITIS VACCINE
by: G. N. Leonova, et al.
Published: (2014-07-01) -
Experimental Assessment of Possible Factors Associated with Tick-Borne Encephalitis Vaccine Failure
by: Ksenia Tuchynskaya, et al.
Published: (2021-05-01)